Common dating method radioisotope

After entering the body, the radio-labelled pharmaceutical will accumulate in a specific organ or tumour tissue.

Its radioactivity attacks nearby cancer cells with minimal effect on healthy tissue.The most common is technetium-99m, which has its origins as uranium silicide sealed in an aluminium strip placed in the OPAL reactor's neutron-rich reflector vessel surrounding the core.After processing, the resulting molybdenum-99 is removed and placed into devices called technetium generators where it changes to technetium-99m.In fact, they have been used routinely in medicine for more than 30 years.On average, one in every two Australians can expect at some stage in his or her life to undergo a nuclear medicine procedure that uses a radioisotope for diagnostic or therapeutic purposes.